Global Distribution Expansion for LungFit PH
Beyond Air, Inc. (NASDAQ: XAIR) is excited to announce new agreements that extend the international reach of its innovative LungFit PH device. These agreements will enhance the distribution network across four new countries, namely France, Turkey, Romania, and Morocco. This expansion now allows the LungFit PH system to be available in 18 countries worldwide, marking a significant milestone for Beyond Air as it continues to improve access to its technology.
Market Response and Growth Expectations
Following the recent CE Mark approval just weeks ago, Beyond Air is witnessing a surge in global interest for the LungFit PH system. Steve Lisi, the company's Chairman and CEO, highlighted the company's ambition, stating, "With these latest distribution agreements, we are confident in our ability to rapidly scale our international operations. We believe that our commercial experience in the U.S. combined with the support from established distribution partners abroad will facilitate quicker adoption and integration of our technology into healthcare systems".
Current Distribution Partnerships
The following partners are instrumental in enhancing access to the LungFit PH system across various regions:
- Getz Healthcare: Covers Australia, Hong Kong, Malaysia, New Zealand, Pakistan, Philippines, Singapore, Taiwan, Thailand, and Vietnam.
- Saudi Health Services CO: Operates in Saudi Arabia.
- MDC Care Medical Trading: Serves the United Arab Emirates, Oman, and Qatar.
- EUROCARE: Responsible for distribution in France.
- Medelart Healthcare: Takes charge of the market in Turkey.
- Abb Neopuls: Focused on Romania.
- OXYPLUS: Works in Morocco.
Understanding LungFit PH's Benefits
The LungFit PH operates by generating nitric oxide directly from room air, providing a sustainable and efficient alternative to traditional high-pressure cylinders. This innovative technology reduces operational complexities and enhances the sustainability of medical facilities. Notably, it streamlines processes, thereby allowing healthcare professionals to focus more on patient care rather than logistics related to gas management.
The Importance of Nitric Oxide
Nitric Oxide (NO) is a naturally occurring molecule within the body and plays a vital role in various biological functions, particularly in respiratory health. LungFit PH utilizes NO to treat severe lung conditions, especially during emergencies. This tankless solution addresses the critical need for reliable and immediate oxygen therapy, ultimately improving patient outcomes in hospital settings.
Conclusion: A Commitment to Innovation and Health
Beyond Air is unwavering in its commitment to revolutionizing patient care through innovative technologies. The company is also actively pursuing further developments in its broader LungFit portfolio, targeting advanced therapies for severe lung infections, neurological disorders, and more. The recent expansion of distribution partnerships signals a bright future for Beyond Air and its mission to improve the quality of life for patients globally.
Frequently Asked Questions
What is LungFit PH?
LungFit PH is a medical device developed by Beyond Air that generates nitric oxide from room air to treat respiratory conditions.
How many countries does LungFit PH operate in?
With the latest agreements, LungFit PH is now available in 18 countries worldwide.
What are the key benefits of using LungFit PH?
This device eliminates the need for high-pressure cylinders, streamlining operations and enhancing safety and sustainability in hospitals.
Who are Beyond Air's distribution partners?
Distribution partners include Getz Healthcare, Saudi Health Services CO, MDC Care Medical Trading, EUROCARE, Medelart Healthcare, Abb Neopuls, and OXYPLUS.
What role does nitric oxide play in respiratory health?
Nitric oxide is essential in treating various respiratory ailments by facilitating improved blood flow and oxygen delivery in the lungs.
